eCTD submission preparation FDA TGA

FDA & TGA Submission Services

eCTD Submission Services

IND, NDA, ANDA, BLA, 505(b)(2), DMF and ARTG dossiers — prepared, quality-reviewed and published in eCTD format for FDA and TGA lodgement. One team managing authoring, QA and eCTD publishing end-to-end.

IND · NDA · BLA · ANDA

FDA application types

CTD/eCTD

Dossier format expertise

FDA + TGA

Dual-agency submissions

QA-reviewed

Every submission

Application types

Every major FDA and TGA submission type

We manage submissions across the full range of FDA application types and TGA dossier formats — from first-in-human IND through to full marketing applications.

INDFDA

Investigational New Drug Application

Pre-clinical and Phase 1 through Phase 3 IND submissions, amendments and annual reports.

NDAFDA

New Drug Application

Full 505(b)(1) NDA and 505(b)(2) applications — all CTD modules authored, QA-reviewed and eCTD-published.

ANDAFDA

Abbreviated New Drug Application

Generic drug submissions including bioequivalence documentation, labeling and eCTD formatting.

BLAFDA

Biologics License Application

BLA submissions for biologics and biosimilars — complex multi-module dossiers managed end-to-end.

505(b)(2)FDA

505(b)(2) Application

Hybrid applications relying on published literature or prior FDA findings — bridging strategy and submission.

DMFFDA

Drug Master File

Type II and Type III DMF preparation and annual updates for API and excipient manufacturers.

ARTGTGA

Australian Register of Therapeutic Goods

Full CTD/eCTD dossiers for TGA prescription and OTC medicine registrations.

DeviceFDA + TGA

Medical Device Submissions

510(k), De Novo and ARTG device dossiers formatted and lodged to agency standards.

Our process

From gap analysis to lodgement

01

Gap analysis

We review your data package against the target agency's current guidance and identify missing or deficient elements before authoring begins.

02

Module authoring

Our consultants author or co-author CTD modules — CMC, nonclinical and clinical overviews — with cross-module consistency built in from the start.

03

Internal QA review

Every submission goes through a structured quality review: scientific consistency across modules, formatting against agency guidance, completeness check.

04

eCTD publishing

We publish the validated eCTD sequence using current publishing tools, verify the XML backbone, run validation checks and produce a submission-ready package.

05

Lodgement and tracking

We lodge the submission with FDA or TGA and track it through the review process — managing information requests and maintaining submission history.

Ready to submit?

Get your submission right the first time

A poorly prepared submission costs months. Book a free consultation and we will assess your data package and outline the submission plan.